Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | LV-NY-ESO TCR/sr39TK PBSC |
Trade Name | |
Synonyms | LV-NYESO TCR/sr39TK PBSC |
Drug Descriptions |
LV-NYESO TCR/sr39TK PBSC are peripheral blood stem cells that have been engineered to express a NY-ESO-1-specific T-cell receptor and the sr39TK cell suicide gene, which may enhance anti-tumor immune response (PMID: 30409823) |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | C146940 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Aldesleukin + LV-NY-ESO TCR/sr39TK PBSC + RV-NY-ESO TCR PBMC | Aldesleukin LV-NY-ESO TCR/sr39TK PBSC RV-NY-ESO TCR PBMC | 0 | 2 |
LV-NY-ESO TCR/sr39TK PBSC | LV-NY-ESO TCR/sr39TK PBSC | 0 | 0 |